IP Library Granted Patent US 10,192,641
Granted Patent B2
US 10,192,641 · App. 13/317,769 · Granted Jan 29, 2019

Method of generating a dynamic pathway map

Inventors: Charles J. Vaske (Santa Cruz, CA); Stephen C. Benz (Santa Cruz, CA); Joshua M. Stuart (Santa Cruz, CA); David Haussler (Santa Cruz, CA)
Assignee: The Regents of the University of California
G16H50/30G06F17/30318G06F19/12G06F19/20G06F19/24G06F19/3456G06F19/3475G06F19/3481G16H50/20Y02A90/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,192,641
App. No.
13/317,769
Granted
Jan 29, 2019
Kind
B2
Abstract

A method of generating a dynamic pathway map (DPM) is provided. The method includes accessing a model database that stores a probabilistic pathway model that comprises a plurality of pathway elements, a first number of the plurality of pathway elements are cross-correlated and assigned an influence level for at least one pathway on the basis of known attributes, a second number of the plurality of pathway elements are cross-correlated and assigned an influence level for at least one pathway on the basis of assumed attributes. The method includes measuring a patient sample to identify measured attributes of the patient sample and using a plurality of the measured attributes of the patient sample, via an analysis engine, to modify the probabilistic pathway model to obtain the DPM, wherein the DPM has reference pathway activity information for a particular pathway, the reference pathway indicating deviations from the probabilistic pathway model.

Claims (19)

1. A processor-based method of generating a dynamic pathway map (DPM), comprising:

accessing a model database that stores a probabilistic pathway model that comprises a plurality of pathway elements;

assigning an influence level for at least one pathway of a first number of the plurality of pathway elements on the basis of known attributes;

cross correlating the first number of the plurality of pathway elements;

assigning an influence level for at least one pathway on the basis of assumed attributes;

measuring a patient sample to identify measured attributes of the patient sample, based on a genome-scale assay;

modifying the probabilistic pathway model by using a plurality of the measured attributes for a plurality of elements of the patient sample, via an analysis engine, the modifying comprising:

obtaining a factor graph representing states of entities in a cell and interactions between the entities, wherein the factor graph encodes a state of the cell using a random variable for each entity and wherein the factor graph has reference pathway activity information for a particular pathway, the reference pathway indicating deviations from the probabilistic pathway model; and

formulating a treatment option for the patient based on the reference pathway activity of the factor graph, wherein at least one of the above method operations is performed through a processor.

2. The method of claim 1 wherein the pathway is within a regulatory pathway network, a signaling pathway network, or a network of distinct pathway networks.

3. The method of claim 1 wherein the pathway element is a protein selected from the group consisting of a receptor, a hormone binding protein, a kinase, a transcription factor, a methylase, a histone acetylase, and a histone deacetylase or a nucleic acid is selected from the group consisting of a genomic regulatory sequence, a regulatory RNA, and a trans-activating sequence.

4. The method of claim 1 wherein the reference pathway activity information is specific with respect to a normal tissue, a diseased tissue, an ageing tissue, or a recovering tissue.

5. The method of claim 1 wherein the known attribute is selected from the group consisting of a compound attribute, a class attribute, a gene copy number, a transcription level, a translation level, and a protein activity.

6. The method of claim 1 wherein the assumed attribute is selected from the group consisting of a compound attribute, a class attribute, a gene copy number, a transcription level, a translation level, and a protein activity.

7. The method of claim 1 wherein the measured attributes are selected from the group consisting of a mutation, a differential genetic sequence object, a gene copy number, a transcription level, a translation level, a protein activity, and a protein interaction.

8. The method of claim 1 , wherein modifying the probabilistic pathway model comprises:

converting the probabilistic pathway into a directed graph with each edge of the directed graph labeled with one of a positive or a negative influence.

9. The method of claim 8 further comprising:

converting each of the interactions to a single edge of the directed graph.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2012
From: VASKE, CHARLES J; BENZ, STEPHEN C; STUART, JOSHUA M; HAUSSLER, DAVID
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 029041/0800 →
Continuity (3)
Continuation In Part 13068002 · Apr 29, 2011
Provisional Application 61343575 · Apr 29, 2010
Related Publication 20120158391A1 · Jun 21, 2012